Overview:

Dr. Dhiraj Gupta is a distinguished Consultant Cardiologist at the Liverpool Heart and Chest Hospital (LHCH), where he is an integral part of the largest cardiac rhythm unit in the United Kingdom Read More... . He brought his expertise to LHCH in March 2007, following a tenure at St. Bartholomew’s Hospital in London. Dr. Gupta holds an honorary Senior Lecturer position at Imperial College London, where he collaborates closely with the Royal Brompton and Harefield Hospitals in London to pursue his research interests.

Throughout his illustrious career, Dr. Gupta has demonstrated exceptional academic prowess, consistently earning distinctions during his undergraduate years from 1988 to 1994. His passion for cardiology led him to receive the Commonwealth Fellowship in Cardiac Electrophysiology in 2000, providing intensive training at prestigious teaching hospitals across London.

Dr. Gupta’s professional journey spans several renowned institutions globally, including impactful visits to Bordeaux and Zurich, where he exchanged expertise in invasive electrophysiology with world-leading experts. His commitment to excellence has been recognized with the National Health Service Clinical Excellence Award in 2010.

Specializing in disorders of heart rhythm, Dr. Gupta practices comprehensive cardiology at LHCH, focusing particularly on the assessment and management of patients with symptoms such as palpitations, dizziness, and breathlessness. He is highly regarded for his expertise in curative ablation procedures, using advanced 3D mapping technologies to enhance success rates, especially in treating Atrial Fibrillation.

Dr. Gupta is not only a clinician but also a dedicated researcher at Imperial College London, where he leads investigations into the mechanisms linking risk factors to atrial fibrillation. His research extends to measuring quality of life in patients undergoing rhythm disturbance therapies and refining catheter ablation techniques for long-standing persistent atrial fibrillation, aiming to improve patient outcomes globally. Read Less